Location History:
- Kyoto, JA (1977)
- Tsuzuki, JP (1985 - 1992)
- Kyoto, JP (1979 - 2000)
- Tsuzuki-gun, JP (1997 - 2001)
- Kyotanabe, JP (2001 - 2015)
Company Filing History:
26 out of 1,858 
1 out of 55 
1 out of 3,509 
Years Active: 1977-2015
Title: Innovations of Susumu Iwasa: Pioneering Advances in Insulin Resistance
Introduction
Susumu Iwasa, a prominent inventor based in Kyotanabe, Japan, has made significant contributions to the field of medical science. With an impressive portfolio of 27 patents, he has focused his research on developing solutions to improve insulin resistance, which is crucial in the management of diabetes and related conditions.
Latest Patents
Among his latest innovations are several groundbreaking patents that specifically address insulin resistance. One of these patents introduces a method of screening substances to improve insulin resistance, encompassing an insulin resistance marker and methods for evaluating the condition. This marker includes a polypeptide made up of a continuous sequence of at least 15 amino acids derived from a specific proepithelin protein sequence, identified in SEQ ID NO: 1. Additionally, the patent covers polynucleotides that are essential in encoding this amino acid sequence, providing a robust approach to understanding and addressing insulin resistance.
Another noteworthy patent describes a sustained-release preparation of physiologically active polypeptides, emphasizing its production method. This innovative process involves dispersing a polypeptide into a biodegradable polymer within an organic solvent solution and subsequently removing the solvent. By lyophilizing the aqueous solution, Iwasa ensures high stability and ease of handling, leading to an industrially viable method for producing sustained-release preparations with optimized release ratios and high entrapment efficiencies.
Career Highlights
Susumu Iwasa has collaborated with notable organizations throughout his career. He has worked at Takeda Chemical Industries, Inc., a leading pharmaceutical company, and served at the Tokyo Metropolitan Institute of Medical Science, where he furthered his research and development initiatives. His expertise and innovative approach have garnered recognition and respect within the scientific community.
Collaborations
Iwasa's work has led to fruitful collaborations with distinguished colleagues such as Yutaka Yamagata and Masafumi Misaki. Together, they have explored new avenues in medical research, pushing the boundaries of what is possible in the field of insulin resistance and related treatments.
Conclusion
Susumu Iwasa's contributions to the realm of inventions related to insulin resistance exemplify the potential of innovative research to transform healthcare. Through his numerous patents and collaborative efforts, he continues to pave the way for new therapeutic solutions that can significantly enhance the quality of life for individuals affected by insulin resistance and diabetes.